Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Purpura, Thrombocytopenic, Idiopathic × 1 year × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 2758 Neoplasms 2232 Carcinoma, Non-Small-Cell Lung 1678 Prostatic Neoplasms 1503 Colorectal Neoplasms 1219 Lung Neoplasms 1147 Multiple Myeloma 846 Neoplasm Metastasis 821 Leukemia, Myeloid, Acute 789 Pancreatic Neoplasms 765 Ovarian Neoplasms 721 Melanoma 708 Carcinoma, Hepatocellular 660 Recurrence 580 Squamous Cell Carcinoma of Head and Neck 575 Brain Neoplasms 575 Stomach Neoplasms 570 Head and Neck Neoplasms 517 Lymphoma 501 Glioblastoma 500 Uterine Cervical Neoplasms 475 Precursor Cell Lymphoblastic Leukemia-Lymphoma 469 Carcinoma, Renal Cell 451 Triple Negative Breast Neoplasms 445 Endometrial Neoplasms 425 Urinary Bladder Neoplasms 417 Colonic Neoplasms 416 Hematologic Neoplasms 411 Lymphoma, Non-Hodgkin 399 Sarcoma 384

Interventions

Inosine Triphosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06444477 2026-01-26

MATAC

University Hospital, Bordeaux

Neoplasms, Purpura, Thrombocytopenic, Idiopathic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡